Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Pharmaseal
Pharmaseal
X
LinkedIn
Trending Articles
Fluidic Sciences relaunches Microfluidic Diffusional Sizing technology to refine protein-protein interaction analysis
The Microfluidic Diffusional Sizing (MDS) technology allows scientists better options when characterising a protein's biophysical properties
Ensuring pharma supply chain resilience amidst a dynamic global landscape
Global events can significantly disrupt the phamaceutical supply chain, but companies must take steps to ensure it remains consistent in times of adversity
Cost, compliance and quality: the benefits of outsourcing to India
With pressure to find the next blockbuster drug mounting, pharmaceutical companies in the 1990s took advantage of lower-cost outsourcing options to target multiple drug...
Novel immune cell and inflammation regulator, MICL, discovered
The receptor could be a novel target for inflammatory diseases such as arthritis and severe COVID-19
AstraZeneca & Daiichi Sankyo's Enhertu bags another approval for gastric cancer applications
The HER2-targeting ADC has received conditional approval owing to the results of the DESTINY-Gastric06 Phase II trial
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Pharmaseal Engility platform selected by ultrasound tech company
The platform is interoperable with other eClinical solutions, the company says
Regulatory
Pharmaseal reaches milestone in crowdfunding campaign
The company was first founded in 2016
Medical Devices
Pharmaseal launches new Clinical Trial Management System
Engility clinical trial management system has been launched and is the first product to be released from the Engility B2B platform
Subscribe now